Actinium Pharmaceuticals, Inc.
Price Action
Technical Summary
WEAKENINGActinium Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 22), showing significant lag compared to the market leaders. Earnings growth of 65% provides fundamental context to the price action. Investors should exercise caution due to high volatility (66% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.10 | -4.76% | BELOW |
| 50 SMA | $1.18 | -11.72% | BELOW |
| 100 SMA | $1.15 | -9.41% | BELOW |
| 150 SMA | $1.24 | -15.77% | BELOW |
| 200 SMA | $1.31 | -20.37% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ATNM in an uptrend right now?
ATNM has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ATNM overbought or oversold?
ATNM's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is ATNM outperforming the market?
ATNM has a Relative Strength (RS) Rating of 22 out of 99. ATNM is currently lagging the broader market.
Where is ATNM in its 52-week range?
ATNM is trading at $1.04, which is 55% of its 52-week high ($1.89) and 10% above its 52-week low ($0.95).
How volatile is ATNM?
ATNM has a Beta of 0.93 and 52-week volatility of 66%. It's less volatile than the S&P 500 - generally more stable.